Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. ACK Natural, LLC recently disclosed that there are quarantined product packages for which verifiable test results cannot be produced because they were fully sold. the “Effective Date”). Factual Findings.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

SEPTEMBER 23, 2021

Tracking recent data from within the last year (following the publication of the DEA Interim Final Rule which added confusion to the delta-8 legality question), more than a dozen hospital or emergency room visits and hundreds of calls to poison control were reported. Delta-8 THC products should be kept out of the reach of children and pets.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. To fully understand this definition, you also need to know two other legal definitions: Medical marijuana treatment center. What law legalized medical marijuana in Florida?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JULY 23, 2019

Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. No data is available regarding prescriptions written in respect of secondary care. The Regulations define a CBPM as a preparation or product that. (a) Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

JULY 30, 2019

The same cannot be said for opioid treatment. Florida has existing integrated quality and safety control components due to the regulation that all Florida cannabis products are Phylos Certified. and one in China, for quality, health and safety issues: such as heavy metal, insecticide, pesticide levels.

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

OCTOBER 15, 2021

But consumers who buy products in this unregulated CBD market have no access to data showing the actual CBD and THC content of these products and have no way to determine whether these products are free of adulterants. . S ee FD&C Act Section 301(ll) and Section 201(ff)(3)(B).

Food 52

Food Cannabinoids Hemp Legalization 52

SpeedWeed

JULY 19, 2021

The document in question was a 2020 safety study of the vape cartridge additive phytol. The data contained in that report has rocked the cannabis vaping world. The data was far worse than he imagined. Phytol, according to the data in the study, appeared unsafe to inhale. Its contents floored him. David Downs/Leafly).

Vaping 52

Vaping Terpenes Data Research and Development 52

CannaMD

MAY 14, 2020

CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements. Safety of production and packaging. Why Do People Like Marijuana Edibles?

Edibles 105

Edibles Marijuana THC Vaping 105

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

The Cannigma

OCTOBER 19, 2021

Arguably, one doesn’t need to see any scientific data to know that the mixing of cannabis and alcohol is more common with younger cannabis users. A shortage of fluids makes a severe hangover the next morning more likely, and dehydration can require medical treatment in severe cases. CBD and alcohol safety.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Otherside Farms

DECEMBER 10, 2019

CBD is additionally being investigated as an available treatment for pain, anxiety, and schizophrenic psychosis symptoms in humans. According to experts, CBD is used due to its healing properties, though there’s no conclusive data on this use. The safety and risks of CBD for dogs haven’t but been researched.

Oil 18

Oil CBD Pets Blood Pressure 18

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. It has the – you assume safety, at least to a certain level. Though hopefully this will not be the case for much longer.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JANUARY 21, 2019

All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. . The California treatment of pension income is generally the same as federal treatment. 8)Documentation for data or information entered into the track and trace system. (9)All

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

MAY 14, 2022

Senator Patty Murray (D-WA) is currently leading a push to include it in a sweeping package intended to help resolve the country’s ongoing supply chain issues. Further, despite fears that recreational sales might threaten the supply for medicinal users, state data reveals that the medicinal market remained stable. Dentons Speaks.

Banking 52

Banking Recreational Research and Development Cannabis 52